Lithium treatment during pregnancy, delivery, and lactation: an update
- PMID: 2211538
Lithium treatment during pregnancy, delivery, and lactation: an update
Abstract
Because prophylactic lithium treatment is often given to manic depressive women of fertile age, the answers to five questions are pressing: (1) Does lithium administration during pregnancy expose the unborn child to risk of malformations? (2) Does such exposure lead to later developmental anomalies? (3) Do changes in the pharmacokinetics of lithium during pregnancy and delivery require special precautions? (4) Does lithium treatment during pregnancy exert other effects? (5) Is it advisable that women in lithium treatment breastfeed their infants? The author discusses these questions in the light of present-day knowledge and proposes guidelines for lithium treatment during pregnancy, delivery, and lactation.
Similar articles
-
The use of lithium and management of women with bipolar disorder during pregnancy and lactation.J Clin Psychiatry. 1998;59 Suppl 6:57-64; discussion 65. J Clin Psychiatry. 1998. PMID: 9674938 Review.
-
Lithium use during pregnancy.J Fla Med Assoc. 1989 May;76(5):454-6. J Fla Med Assoc. 1989. PMID: 2693580 Review.
-
Association of maternal lithium exposure and premature delivery.J Perinatol. 1993 Mar-Apr;13(2):123-7. J Perinatol. 1993. PMID: 8515304
-
[Lithium and pregnancy; psychiatric aspects].Ned Tijdschr Geneeskd. 1984 Nov 3;128(44):2089-92. Ned Tijdschr Geneeskd. 1984. PMID: 6504203 Dutch. No abstract available.
-
The use of lithium during pregnancy and lactation.J Clin Psychiatry. 1983 Oct;44(10):358-61. J Clin Psychiatry. 1983. PMID: 6358200 Review.
Cited by
-
Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.CNS Drugs. 2009;23(4):331-49. doi: 10.2165/00023210-200923040-00005. CNS Drugs. 2009. PMID: 19374461 Review.
-
A guide to the safety of CNS-active agents during breastfeeding.Drug Saf. 1997 Aug;17(2):127-42. doi: 10.2165/00002018-199717020-00005. Drug Saf. 1997. PMID: 9285203 Review.
-
Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.CNS Drugs. 2009;23(5):397-418. doi: 10.2165/00023210-200923050-00004. CNS Drugs. 2009. PMID: 19453201 Review.
-
Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.Pharm Res. 2004 Jul;21(7):1214-22. doi: 10.1023/b:pham.0000033008.64915.c8. Pharm Res. 2004. PMID: 15290862
-
Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway.BMJ Open. 2017 Mar 1;7(3):e015738. doi: 10.1136/bmjopen-2016-015738. BMJ Open. 2017. PMID: 28249852 Free PMC article.